Seila Lorenzo-Herrero

5PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2022
Immunoglobulin-like transcript 2 blockade restores antitumor immune responses in glioblastoma.

Seila Lorenzo-Herrero, Christian Sordo-Bahamonde, Alejandra Martínez-Pérez

|Apr 30, 2021
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia.

Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P González-Rodríguez

|Apr 30, 2021
BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia.

Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez

|Apr 11, 2020
Mechanisms of Resistance to NK Cell Immunotherapy.

Christian Sordo-Bahamonde, Massimo Vitale, Seila Lorenzo-Herrero

|Feb 07, 2020
Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance.

Marco H Hofmann, Rajeswaran Mani, Harald Engelhardt

Pageof 1